TK1 and breast carcinoma: In this study the use of serum thymidine kinase 1 protein (STK1p) concentration for monitoring the results of treatment (neoadjuvant, surgical and adjuvant) in patients with locally advanced breast cancer was investigated, including determination of the risk of metastatic disease following completion of treatment and prognosis of overall survival.